RhumbLine Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-47,175
| Closed | -$14.9M | – | 4281 |
|
|
2023
Q4 | $14.9M | Sell |
47,175
-312
| -0.7% | -$98.8K | 0.02% | 834 |
|
|
2023
Q3 | $8.03M | Buy |
47,487
+374
| +0.8% | +$63.2K | 0.01% | 1096 |
|
|
2023
Q2 | $10.2M | Buy |
47,113
+3,155
| +7% | +$684K | 0.01% | 1000 |
|
|
2023
Q1 | $7.99M | Buy |
43,958
+1,917
| +5% | +$348K | 0.01% | 1072 |
|
|
2022
Q4 | $8.26M | Buy |
42,041
+1,928
| +5% | +$379K | 0.01% | 1030 |
|
|
2022
Q3 | $9.02M | Buy |
40,113
+9,048
| +29% | +$2.04M | 0.01% | 936 |
|
|
2022
Q2 | $3.93M | Buy |
31,065
+7,985
| +35% | +$1.01M | 0.01% | 1381 |
|
|
2022
Q1 | $2.93M | Buy |
23,080
+669
| +3% | +$84.8K | ﹤0.01% | 1609 |
|
|
2021
Q4 | $2.94M | Sell |
22,411
-239
| -1% | -$31.3K | ﹤0.01% | 1683 |
|
|
2021
Q3 | $2.77M | Buy |
22,650
+539
| +2% | +$65.9K | ﹤0.01% | 1710 |
|
|
2021
Q2 | $2.52M | Buy |
22,111
+3,756
| +20% | +$428K | ﹤0.01% | 1834 |
|
|
2021
Q1 | $2.21M | Sell |
18,355
-1,633
| -8% | -$196K | ﹤0.01% | 1865 |
|
|
2020
Q4 | $2.03M | Buy |
19,988
+190
| +1% | +$19.3K | ﹤0.01% | 1832 |
|
|
2020
Q3 | $1.53M | Sell |
19,798
-3,029
| -13% | -$234K | ﹤0.01% | 1819 |
|
|
2020
Q2 | $2.54M | Buy |
22,827
+8,870
| +64% | +$989K | ﹤0.01% | 1592 |
|
|
2020
Q1 | $1.01M | Buy |
13,957
+8,943
| +178% | +$644K | ﹤0.01% | 1878 |
|
|
2019
Q4 | $378K | Buy |
+5,014
| New | +$378K | ﹤0.01% | 2491 |
|